The Latin America, Middle East and Africa Blood Plasma Derivatives Market would witness market growth of 10.3% CAGR during the forecast period (2022-2028).
A rise in the number of approvals for plasma-derived products and an increase in the number of pharmaceutical manufacturing businesses are the primary drivers driving the blood plasma derivatives industry forward. Furthermore, the development of advanced and enhanced methods for preserving plasma derivatives, sophisticated fractionation procedures, and the availability of unexplored markets in emerging nations are anticipated to provide lucrative potential prospects for the market.
The therapeutic uses of blood plasma derivatives are extensive. These are used to treat a variety of life-threatening illnesses. Blood plasma derivatives are derived from the plasma of blood donors. The expansion of the market for blood plasma derivatives is fueled by the improvement and development of improved methods for preserving these blood plasma derivatives, as well as the introduction of more refined fractionation techniques.
In addition, the increasing prevalence of life-threatening disorders such as HIV, hepatitis, and hemophilia generate demand and potential in the blood plasma derivatives market. Furthermore, several government and non-government activities to organize and promote blood donation camps have resulted in a rise in the collection of human blood. This is accelerating the expansion of the market for blood plasma derivatives.
The UAE healthcare business has evolved to meet the changing needs of the people and the country's desire to become a local medical tourism hub. The COVID-19 pandemic has spurred the United Arab Emirates to recommit to healthcare investment. Since public spending contributes to more than two-thirds of overall healthcare expenditures, the government's commitment to the healthcare industry is among the key growth catalysts within the UAE's healthcare market. This factor would increase the adoption of the blood plasma derivatives market in the UAE and the growth of the regional blood plasma derivatives market would flourish in the coming years.
The Brazil market dominated the LAMEA Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $1,114.2 Million by 2028. The Argentina market is anticipated to grow at a CAGR of 10.9% during (2022 - 2028). Additionally, The UAE would showcase a CAGR of 10.1% during (2022 - 2028).
Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Blood Plasma Derivatives Market is Predict to reach $72.5 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Immunodeficiency Diseases
- Hypogammaglobulinemia
- Hemophilia
- Von Willebrand's Disease
- Others
By End User
By Type
- Immunoglobulin
- Albumin
- Factor VIII
- Factor IX
- Hyperimmune Globulin
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Biotest AG
- LFB S.A.
- CSL Limited
- Octapharma AG
- Kedrion S.p.A
- Sanofi S.A.
- Fusion Health Care Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Blood Plasma Derivatives Market, by Application
1.4.2 LAMEA Blood Plasma Derivatives Market, by End User
1.4.3 LAMEA Blood Plasma Derivatives Market, by Type
1.4.4 LAMEA Blood Plasma Derivatives Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Blood Plasma Derivatives Market
Chapter 4. LAMEA Blood Plasma Derivatives Market by Application
4.1 LAMEA Immunodeficiency Diseases Market by Country
4.2 LAMEA Hypogammaglobulinemia Market by Country
4.3 LAMEA Hemophilia Market by Country
4.4 LAMEA Von Willebrand's Disease Market by Country
4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Blood Plasma Derivatives Market by End User
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinics Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Blood Plasma Derivatives Market by Type
6.1 LAMEA Immunoglobulin Market by Country
6.2 LAMEA Albumin Market by Country
6.3 LAMEA Factor VIII Market by Country
6.4 LAMEA Factor IX Market by Country
6.5 LAMEA Hyperimmune Globulin Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Blood Plasma Derivatives Market by Country
7.1 Brazil Blood Plasma Derivatives Market
7.1.1 Brazil Blood Plasma Derivatives Market by Application
7.1.2 Brazil Blood Plasma Derivatives Market by End User
7.1.3 Brazil Blood Plasma Derivatives Market by Type
7.2 Argentina Blood Plasma Derivatives Market
7.2.1 Argentina Blood Plasma Derivatives Market by Application
7.2.2 Argentina Blood Plasma Derivatives Market by End User
7.2.3 Argentina Blood Plasma Derivatives Market by Type
7.3 UAE Blood Plasma Derivatives Market
7.3.1 UAE Blood Plasma Derivatives Market by Application
7.3.2 UAE Blood Plasma Derivatives Market by End User
7.3.3 UAE Blood Plasma Derivatives Market by Type
7.4 Saudi Arabia Blood Plasma Derivatives Market
7.4.1 Saudi Arabia Blood Plasma Derivatives Market by Application
7.4.2 Saudi Arabia Blood Plasma Derivatives Market by End User
7.4.3 Saudi Arabia Blood Plasma Derivatives Market by Type
7.5 South Africa Blood Plasma Derivatives Market
7.5.1 South Africa Blood Plasma Derivatives Market by Application
7.5.2 South Africa Blood Plasma Derivatives Market by End User
7.5.3 South Africa Blood Plasma Derivatives Market by Type
7.6 Nigeria Blood Plasma Derivatives Market
7.6.1 Nigeria Blood Plasma Derivatives Market by Application
7.6.2 Nigeria Blood Plasma Derivatives Market by End User
7.6.3 Nigeria Blood Plasma Derivatives Market by Type
7.7 Rest of LAMEA Blood Plasma Derivatives Market
7.7.1 Rest of LAMEA Blood Plasma Derivatives Market by Application
7.7.2 Rest of LAMEA Blood Plasma Derivatives Market by End User
7.7.3 Rest of LAMEA Blood Plasma Derivatives Market by Type
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview
TABLE 1 LAMEA Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 4 LAMEA Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 5 LAMEA Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 16 LAMEA Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 17 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 24 LAMEA Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 25 LAMEA Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Albumin Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Albumin Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 39 Brazil Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 40 Brazil Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 41 Brazil Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 42 Brazil Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 43 Brazil Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 44 Brazil Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 45 Brazil Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 46 Brazil Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 47 Argentina Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 48 Argentina Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 49 Argentina Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 50 Argentina Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 51 Argentina Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 52 Argentina Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 53 Argentina Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 54 Argentina Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 55 UAE Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 56 UAE Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 57 UAE Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 58 UAE Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 59 UAE Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 60 UAE Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 61 UAE Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 62 UAE Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 65 Saudi Arabia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 66 Saudi Arabia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 67 Saudi Arabia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 68 Saudi Arabia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 69 Saudi Arabia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 70 Saudi Arabia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 71 South Africa Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 72 South Africa Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 73 South Africa Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 74 South Africa Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 75 South Africa Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 76 South Africa Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 77 South Africa Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 78 South Africa Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 79 Nigeria Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 80 Nigeria Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 81 Nigeria Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 82 Nigeria Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 83 Nigeria Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 84 Nigeria Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 85 Nigeria Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 86 Nigeria Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 89 Rest of LAMEA Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 90 Rest of LAMEA Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 91 Rest of LAMEA Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of LAMEA Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 93 Rest of LAMEA Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 94 Rest of LAMEA Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 95 Key Information – Bayer AG
TABLE 96 Key Information – Takeda Pharmaceutical Company Limited
TABLE 97 Key information – Grifols, S.A.
TABLE 98 key information – Biotest AG
TABLE 99 Key Information – LFB S.A
TABLE 100 key Information – CSL Limited
TABLE 101 Key Information – Octapharma AG
TABLE 102 key Information – Kedrion S.p.A
TABLE 103 Key Information – Sanofi S.A.
TABLE 104 Key Information – Fusion Health Care Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.
FIG 3 Recent strategies and developments: Kedrion S.p.A